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Introduction. The antiproliferative effect of eleven neolignans, two lignans and one diterpene 
isolated from three Lauraceae plants, four benzofurans and two bicyclooctanes synthetic derivatives 
was evaluated in vitro on a set of five human cancer cells from solid tumors with a high incidence in 
Colombia.
Objective. To evaluate the cytotoxic effect of twenty compounds on the tumor cell lines HeLa, A-549, 
Hep-2, PC-3, and MCF-7.
Materials and methods. Fourteen natural compounds were isolated by chromatographic techniques 
from three native colombian plants (Pleurothyrium cinereum, Ocotea macrophylla and Nectandra 
amazonum), whose structures were established by spectroscopic methods; six synthetic derivatives 
were prepared by oxyarylation and diazomethane methylation. Antiproliferative effect and cell recovery 
were performed by means of in vitro treatment of tumor cell lines with test compounds, evaluating cell 
viability by resazurin staining. 
Results. Among test compounds, only neolignans ocophyllal A, cinerin D, kaurenoic acid, two 
benzofuran-derivatives, and synthetic (-)-cinerin A were found to have antiproliferative effect at different 
levels. Bicyclooctanoids as well as kaurenoic acid exhibited activity against all human cancer cells 
while benzofuranoids showed selective activity against HeLa. Furthermore, compounds (-)-cinerin A 
and kaurenoic acid exhibited total lethal effect against all-five cell lines and PC-3, Hep-2, and A549 cell 
lines, respectively. 
Conclusion. Test compounds exhibiting antiproliferative activity showed interesting results, which 
would promote their use as lead compounds on further studies for anticancer agents development.
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Efecto citotóxico de algunos compuestos naturales aislados de plantas Laureaceae y derivados 
sintéticos 
Introducción. El efecto contra la proliferación celular de once neolignanos, dos lignanos y un diterpeno, 
aislados de tres plantas de la familia Lauraceae, y cuatro benzofuranos y dos biciclooctanos sintéticos, 
fue evaluado in vitro sobre cinco líneas celulares derivadas de tumores sólidos de alta incidencia en 
Colombia.
Objetivo. Evaluar el efecto citotóxico de veinte compuestos sobre las líneas tumorales HeLa, A-549, 
Hep-2, PC-3 y MCF-7.
Materiales y métodos. Los 14 compuestos de origen natural fueron aislados de tres plantas nativas 
colombianas (Pleurothyrium cinereum, Ocotea macrophylla y Nectandra amazonum) por técnicas 
cromatográficas y se establecieron sus estructuras por métodos espectroscópicos, y los seis derivados 
sintéticos fueron preparados mediante reacción de oxiarilación y metilación con diazometano. El efecto 
contra la proliferación y la recuperación celular se hicieron mediante tratamiento in vitro de las líneas 
tumorales con los compuestos , evaluando la viabilidad celular por tinción con resazurina.
Resultados. Entre los compuestos evaluados, solamente ocofilal A, cinerina D, ácido kaurenoico, 
dos benzofuranos y la (-)-cinerina A sintética presentaron actividad contra la proliferación celular en 
diferentes niveles. Los biciclooctanos, así como el ácido kaurenoico, fueron activos contra todas 
las líneas celulares, mientras que los benzofuranoides mostraron actividad selectiva contra HeLa. 
Además, la (-)-cinerina A exhibió un efecto letal total contra todas las líneas celulares, mientras que el 
ácido kaurenóico presentó efecto letal total contra PC-3, Hep-2 y A549.
Conclusión. Los compuestos evaluados que exhibieron actividad contra la proliferación celular 
mostraron resultados interesantes, lo cual sugiere su potencial uso como cabezas de serie o moléculas 
plantilla en el desarrollo de agentes anticancerígenos.
Palabras clave: productos biológicos, Lauraceae, cribado, diterpenos, in vitro.
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Drug-seeds discovery from natural products has led 
to novel medical advances, mostly including research 
on anti-cancer agents through exploration for sources 
of novel cytotoxic compounds (1). Cytotoxicity studies 
can be regarded when compounds exhibit a potential 
biological activity on cell damage, whose causes might 
be related to either agent concentration or exposure 
time for cells to these agents, which compromises cell 
viability (2).
Cancer is one of the leading causes of death 
worldwide, being the main reason to searching for 
new antineoplastic agents, mostly from natural origin, 
which has became an important research approach 
(3). Currently, the drugs used to treat cancer may 
have two limitations: reduced activity, on the one 
hand, or acquired resistance by tumor cells, on the 
other (4). In Colombia, recent statistics indicated that 
the highest incidences of cancer disease correspond 
to breast, cervix, stomach, leukemia, colon, and 
prostate cancer (5). Therefore, performing in vitro 
screening in order to discover cytotoxic agents 
against tumor cell lines still remains as an important 
objective of anticancer research (6).
Lignans and neolignans (C6C3 dimers to the shikimate 
biosynthetic pathway) (7), are well-recognized for 
their wide-range of important biological activities, 
because they have been used as lead compounds 
for the development of new drugs (8). An important 
bioactive class of these type of natural products 
is related to the benzofuran moiety, which has 
exhibited antitumor (8), antiangiogenic (8), cytotoxic 
(9-11), antileishmanial (11), antitrypanosomal (12), 
antibacterial (13), PAF-antagonistic (14), among 
others, the cytotoxicity being a significant property 
of this type of compounds (8-11). Lauraceae plants 
are well-known to contain benzofuran neolignans 
as well as bicyclo[3.2.1]octane neolignans (7), 
which are considered as benzofuran-derived (15), 
and they have exhibited excellent PAF-antagonistic 
activity (16).
As part of our research on bioactive natural 
compounds, the phytochemical exploration carried 
out on the leaves of three Lauraceae plants 
(Pleurothyrium cinereum, Ocotea macrophylla and 
Corresponding author: 
Fabio Ancízar Aristizábal, Laboratorio de Farmacogenética del 
Cáncer, Departamento de Farmacia, Universidad Nacional de 
Colombia, Carrera 30 Nº 45-03, Edificio 450, Oficina 206, AA 
14490, Bogotá, D.C., Colombia
Teléfono: (571) 314 5000 extensión14643; fax: (571) 316 5060
faaristizabalg@unal.edu.co 
Recibido: 24/09/10; aceptado:28/04/11
Nectandra amazonum) yielded five benzofuran 
neolignans 1-5, six bicyclo[3.2.1]octane neolignans 
6-11, two diastereomeric dibenzylbutane lignans 
12-13 and a diterpene 14. Including a group of 
six synthetic neolignan derivatives 15-20, the 
naturally-occurring compounds were screened in 
order to determine their in vitro antiproliferative 
effect on a set of five human cancer cells consisting 
of cervical carcinoma HeLa, lung carcinoma A-549, 
larynx carcinoma Hep-2, prostate adenocarcinoma 
PC-3, and breast carcinoma MCF-7. Structures 
of test compounds were determined by extensive 
spectroscopic analyses, and their absolute 
configuration was defined by circular dichroism 
(CD) comparing with data reported in the literature 
for related compounds.
Materials and methods
General experimental procedures
CD spectra were obtained using a JASCO J-720 
spectropolarimeter. 1H and 13C Nuclear Magnetic 
Resonance (NMR) spectra were recorded 
on a Bruker Avance 400 spectrometer, using 
tetramethylsilane (TMS) as internal shift reference. 
High Resolution Mass Spectrometry (HRMS) was 
determined on a Shimadzu LCMS-IT-TOF (with an 
electrospray (ESI) source and in the positive ion 
mode) mass spectrometer. Cell growth indications 
were performed by resazurin method using a 
TECAN GENios plate reader with excitation 
wavelength at 535nm and emission at 595nm.
Plant material
Whole plants of Pleurothyrium cinereum, Ocotea 
macrophylla and Nectandra amazonum were 
collected in different regions of Colombia: Tumaco 
county, Department of Nariño, on the Nocaima–
Vergara road at Nocaima county, Department of 
Cundinamarca, and near the biological station 
“El Zafire”, 6 hours from Leticia city, Department 
of Amazonas, respectively. Reference specimens 
(numbers COL518334 for P. cinereum, COL517191 
for O. macrophylla, COL519818 for N. amazonum) 
are kept at Herbario Nacional Colombiano, 
Universidad Nacional de Colombia.
Extraction and isolation
Detailed extraction and isolation processes, and 
spectroscopic features for the test compounds 
were previously reported (19-24) (figure 1) including 
liliflol A 1 (17), 3’-methoxy-3,4-methylendioxy-
4’,7-epoxy-nor-8.5’-neolignan-7.8’-diene 2 (12), 
(+)-licarin A 3 (18), ocophyllal A 4 (19), (+)-mirandin 
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A 5 (20), cinerin C 6 (21), (-)-cinerin D 7 (21), 2’-
epi-guianin 8 (19), ocophyllol C 9 (19), kadsurenin 
C 10 (22), nectamazin C 11 (23), meso- and threo-
3,4,5,3’,4’,5’-hexamethoxy-8.8’-neolignan 12-13 
and kaurenoic acid 14 (24). Compounds 2, 5-7 were 
isolated from P. cinereum, compounds 4, 8-9 from 
O. macrophylla, and compounds 1, 3, 10-11 from N. 
amazonum, using conventional chromatographic 
methods.
Chemical synthesis
Benzofurans 15-17 were synthesized via metal-
catalyzed oxyarylation reaction (25). Benzofuran 
18 was obtained by direct O-methylation of 
liliflol A using diazomethane prepared in situ by 
decomposition of N-methyl-N-nitrosourea, following 
the reported methodology (26). Bicyclooctanes 
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Figure 1. Structures of compounds 1-20.
19-20 were obtained by HPLC kinetic resolution 
on a racemic product [(±)-cineric A], which 
was synthesized following a reaction protocol 
developed by us, starting from the corresponding 
benzofuran precursor (25,35). Semi-preparative 
Kinetic resolution was performed in a HPLC system 
consisting of a Jasco PU-980 pump and Jasco 
multiwavelength detector MD-910 equipped with a 
Chiralcel OD-H semi-preparative column (100x10 
mm) (Daicel Chemical Industries LTD) isocratically 
eluted with hexane: iPrOH 93:7 at a flow rate of 5 
ml/min. Levorotatory compound, 20 was eluted for 
11.3 min, and dextrorotatory 19, for 13.2 min.
Cytotoxicity assay
The cytotoxic effect of test compounds 1-20 was 
evaluated in vitro against a panel of five human 
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cancer cell-lines including cervical carcinoma 
HeLa, lung carcinoma A-549, larynx carcinoma 
Hep-2, prostate adenocarcinoma PC-3 and breast 
carcinoma MCF-7 (all adherent growth), derived 
from human solid tumors, obtained from the Cell 
Bank of the Laboratorio de Inmunología at Instituto 
Nacional de Cancerología de Colombia in Bogotá. 
All tumor cell-lines were cultured in Minimum 
Essential Medium (MEM) supplemented with 5% 
fetal bovine serum (FBS), gentamicin (50 mg/ml) 
and sodium bicarbonate (2.2 g/L), in 75 cm2 boxes 
for sterile cultures, and incubated under standard 
conditions (27). Medium was changed every two 
days for maintaining the culture by washing cells 
with phosphate buffer solution (PBS) 298 mOsm/L, 
pH= 7.3. Cultures with 90% confluence were treated 
with 0.025% trypsin solution and 0.03% EDTA for 5 
minutes at 37°C, obtaining a cell suspension which 
was counted in a Neubauer chamber by trypan blue 
exclusion method. Cell growth was ensured with 
minimal essential medium (MEM) supplemented 
with bovine fetal serum (FBS) and preserved with 
antibiotic to achieve the appropriate cell density 
according to each cell line, using 96-well plates (100 
μl/well). Incubation conditions were maintained in a 
moistened atmosphere at 37°C and 5% CO2.
After adjusting the cell densities established by us 
in previous studies (28-32), cells were seeded into 
96-well plates, incubated for 24 hours in standard 
conditions to allow cell adhesion to the well surface, 
and after this time, test compounds 1-20 were 
placed as treatments (at three concentrations: 
6, 18 and 54 μg/ml, using three replicates per 
concentration) and doxorrubicin HCl (Ebewe 
Pharma®) as positive control, by up to a volume 
of 100 μl per well, obtained by serial dilution in 
MEM supplemented with 5% FBS (28). After 48 
hours of treatment, the viable cell population on the 
plates was determined using 100 μl of rezasurin 
(0.25 mg/ml in PBS), which was placed in each 
well with medium without supplement to avoid 
interferences during test. Plates were incubated 
for 4 hours under standard conditions, and then 
read using a TECAN GENios reader. Resorufin 
formed by rezasurin reduction contains suitably 
both chromophoric and fluorophoric moieties, 
allowing performing absorbance (at 570 nm) and/
or fluorescence (excitation at 535 nm and emission 
at 595 nm) measurements, in a non-destructive 
testing. It shows almost no cytotoxic activity, 
allowing discrimination of the cytotoxic activity of 
the cytostatic. Supernatant was then carefully 
removed and 100 μl of medium supplement was 
added, whose plates were further incubated for 48 
hours, repeating again the procedure described 
above. Resulting values were taken as an indirect 
measure of viable cell mass.
Results
Figure 1 shows the chemical structures of isolated 
compounds 1-20, whose antiproliferative effects 
were established using resazurin, which exhibited 
slightly more sensitivity than MTT for proliferative 
estimation. However, only compounds 4, 7, 14, 16, 
17, and 20 showed a considerable activity against 
the tumor cell-lines at the tested concentrations. 
Table shows the antiproliferative results as survival 
percentage at three concentrations (6, 18, and 54 
μg/ml) for those compounds as a dose-dependent 
behavior. The most important results are described 
below.
Liliflol A, 1, a dihydrobenzofuran neolignan isolated 
from N. amazonum, exhibited no significant 
antiproliferative activity against all the cell lines. An 
O-methylation, using diazomethane prepared in 
situ by decomposition of N-methyl-N-nitrosourea, 
was performed starting from compound 1 to 
yield the synthetic derivative 18 (Figure 2a). The 
antiproliferative effect of 18 remained identical to 
that of 1, indicating no important effect when the 
structure was slightly transformed.
Kaurenoic acid 14 was found to be the most potent 
antiproliferative compound, showing activity against 
the five evaluated human cancer cells lines at three 
concentrations, whose relative survival percentages 
were estimated at 0%. Remarkably, kaurenoic acid 
presented activity against the PC-3 and A-549 cell 
lines, which exhibited resistance as compared with 
the positive control (doxorubicin HCl), Similarly, 
(+)-cinerin D 7 and (-)-cinerin A 20 also showed 
activity against all the tested human cancer cells 
at different levels. Relative survival percentages 
of 7 were 37.2% and 7.4% at 18 and 54 ug/ml, 
respectively, while compound 20 displayed 5.0 
and 0% survival percentages at 18 and 54 μg/ml, 
respectively, against the HeLa cell line. Synthetic 
(±)-cinerin A was separated into its enantiomers 
through semi-preparative HPLC kinetic resolution, 
obtaining (+)-cinerin A 19, and (-)-cinerin A 20 (figure 
2b). Interestingly, the dextrorotatory derivative 19, 
showed no significant activity against all cell lines, 
while the levorotatory enantiomer 20, was active 
against all the tumor cell lines tested.
On the other hand, benzofurans 16, 17 and 4 
exhibited selective activity against the HeLa cell 
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line. Compound 17 was found to be the most potent 
antiproliferative compound among the benzofuran-
type compounds, whose survival percentage 
values were similar at the concentrations tested. 
Furthermore, ocophyllal A, 4, having a benzofuran 
aldehyde moiety, presented activity against A549 
cell line with survival values of 32.0% and 11.2 % 
at 18 and 54 ug/ml, respectively. However, allyl, 
propenyl and chlorobenzofuran 1-3, 15, 18 and 
cyclohexadienone 5 derivatives, bicyclooctane 
neolignans 6, 9, 10 and diarylbutane lignans 12-
13 showed no significant antiproliferative activity 
against the cell lines evaluated with survival values 
of >50%.
After 48 h, medium was replaced by fresh medium, to 
determine the cell recovery by using new resazurin. 
Thus, cell recovery of tested human tumor cell lines 
was qualitatively determined after evaluation of 
the antiproliferative effect. Compounds 20 and 14 
exhibited total lethal effect against four cell lines 
and PC-3, Hep-2, and A549 cell lines, respectively. 
However, it is suggested to carry out trials in shorter 
times to establish the recovery effect, avoiding raised 
additional effects in the development of the test.
In addition, the effects of the most active compounds 
4, 7, 14, 16, 17 and 20, were also tested against the 
MCF-7 breast carcinoma cell line, which has been 
extensively studied by the Pharmacogenetics of 
Cancer Group. This cell line showed survival values 
above 50 percent, indicating that the cytotoxic effect 
Figure 2. (a) Methylation of (+)-liliflol A; (b) kinetic resolution of (±)-cinerina A.
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on this cell line is lower in comparison to the effect 
against other tumor cell lines. Susceptibility of the 
MCF-7 cell line was exhibited in the presence of 
14, 17 and 20 (table 1).
Discussion
At the Pharmacogenetics of Cancer laboratory the 
methods for indirect assessment of cell survival 
using MTT and resazurin (29) were previously 
compared. Resazurin was found to be slightly more 
sensitive than MTT for proliferative estimation, 
leading to use the resazurin method with more 
reliable results, even during recovery time after 
treatment (29). Furthermore, different types of 
controls, as medium, vehicle (DMSO), and growth 
were previously optimized in order to ensure the 
test quatlity (29-32).
Test compounds from natural sources, 1-14, and 
synthetic benzofurans, 15-17, were obtained in 
previous studies (19-25). Here the O-methylation 
of liliflol A, 1, affording 18, and the racemic 
resolution of synthetic (±)-cinerin A into 19 and 20 
are decribed. In a previously reported cytotoxic 
evaluation against the tumor cell lines MCF-7 and 
HCT-8, compound 14 was found to exhibit a 45% 
survival rate at 78 μM (33), and an effect against the 
PC-3 cell-line at 3.7 μg/ml (34); compound 14 also 
showed an IC50 of 1.6 μg/ml in KB cells derived from 
nasopharyngeal cancer (35), results which are in 
agreement with those of the present work. By means 
of electrophoretic analyses, the mode of action of 
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Table 1A. Concentrations used for each molecule of interest in the study (μM). B. Survival percentage results from the citotoxicity 
assay for most potent compounds against five tumor cell lines
A.
 Compounds mw I II III
 4 310,30 19,3 58,0 174,0
 7 402,44 14,9 44,7 134,2
 14 302,45 19,8 59,5 178,5
 16 318,75 18,8 56,5 169,4
 17 240,30 25,0 74,9 224,7
 20 400,42 15,0 45,0 134,9
 Doxorubicin 543,52 11,0 33,1 99,4
 mw: molecular weight
                    B  HeLaa,b cell line
 Compounds I μM II μM III μM
 4  Na  18.3 (±18.2) 7.2 (±2.1)
 7  Na  37.2 (±3.3) 7.4 (±2.1)
 14 0.0(±0,4)  0.0 (±0,4) 0.0 (±0,1)
 16 Na  Na 36.3 (±4.3)
 17 34.2(±3.9)  30.9( ±3.5) 20.8 (±2,9)
 20 Na  5.9(±3.2) 0.0(±0.3)
 Doxorubicin c 110(±1.2)  86.5(±11.2) 15.3(±1.1)
    A549a,b cell line
 4  Na  32.0 ±(3.7) 11.2 ±(2.3)
 7  Na  27.4 ±(16.0) 7.6 ±(6.2)
 14 9.2 ±(12.8)  0.0 ±(0.7) 0.0 ±(0.6)
 16 Na  Na Na
 17 Na  Na Na
 20 Na  0.1 ±(1.1) 0.0 ±(0.5)
 Doxorubicin c 3.6(±0.3)  0.3(±0.1) 0.6(±0.2)
    Hep-2a,b cell line
 4  Na  Na Na
 7  25.5±(23.6)  3.1 ±(1.4) 0.0 ±(0.1)
 14 18.7±(9.8)  0.0±(0.2) 0.0 ±(0.2)
 16 Na  Na Na
 17 Na  Na Na
 20 Na  9.8±(5.1) 0.2 ±(0.3)
 Doxorubicin c 74.7(±0.9)  51.5(±1.8) 36.0(±9.8)
    PC-3,b cell line
 4  Na  Na Na
 7  Na  12.1±(2.0) 0.0±(0.2)
 14 3.1±(1.4)  0.0±(0.1) 0.0±(0.3)
 16 Na  Na Na
 17 Na  Na Na
 20 Na  0.0 ±(0.2) 0.0±(0.1)
 Doxorubicin c 79.1(±2.3)  18.6(±2.3) 14.8(±1.4)
    MCF-7a,b cell line
 4  Na  Na Na
 7  Na  Na Na
 14 Na  Na 0.0±(1.5)
 16 Na  Na Na
 17 Na  Na 13.1±(3.6)
 20 Na  Na 3.3±(1.3)
 Doxorubicin c 64.0(±7.7)  13.0(±2.0) 19.3(±4.5)
a Values are means of three experiments, standard deviation is given in parentheses (Na = not active).
b Negative values are approximated to zero survival percentage.
c Doxorubicin as positive control.
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compound 14 was established as nucleosomal 
fragmentations, indicating apoptotic activity of 14 
involved on differentiation of protein expression 
associated with the regulation of apoptosis (34). 
Our results also indicate that compound 14 exhibits 
significant activity against HeLa, A-549, Hep-2, and 
PC-3 tumor cell lines, showing enhanced activity 
and behavior against HeLa as compared to that 
of doxorubicin HCl (figure 3), which indicated an 
excellent antitumor parameter. These results 
point to the promising activity of compound 14 
for antitumor research purposes as a leading 
compound for structural optimization. Likewise, 
Perseal D, a compound isolated from Persea 
obovatifolia (Lauraceae), having a benzofuran 
aldehyde moiety (like compounds 4, 16, 17), also 
exhibited antiproliferative activity against the A549 
cell line with ED50 of 0.59 μg/ml (10), which indicates 
this chemical skeleton could be a good candidate 
to be used for further antitumor studies.
Conversely, compounds 7 and 20 are related to 
the bicyclooctane core (21), and they share a very 
similar chemical structure (differenced solely by the 
functional group at C-2’). Activity exhibited by these 
two compounds on the HeLa cell line indicated that 
20 possesses a more forceful cytotoxic profile as 
compared to that of 7 (figure 4). Both compounds 
showed similar effect against the PC-3 and A549 
cell lines, while the antiproliferation of compound 
7 was greater to that of 20 against the Hep-2 cell 
line. Interestingly, no significant antiproliferative 
activity was found for the neolignans having an 
OH group at C-4’, as in compounds 6, 8-11 and 
19, with survival values of >50%. Additionally, in 
order to determine the configuration-dependent 
antiproliferative activity of bicyclo[3.2.1]octane 
nuclei, (±)-cinerin A, prepared in a previous work 
by total synthesis from commercially available 
materials (36), were separated into compounds 19 
and 20, enantiomers with a significantly different 
antiproliferative effect. Dextrorotatory enantiomer 
19 showed no relevant cytotoxic activity against 
four cell lines, while levorotatory enantiomer 20 
[which shares an identical absolute configuration 
to that of natural product (-)-cinerin A, which was 
not suitable to be included on this study due to 
a low isolated amount (21)], displayed activity 
towards four cell lines at 54 μg/ml, having the 
greatest antiproliferative effect on cell lines PC-3, 
A549 and Hep-2 at 18 μg/ml. This fact indicated 
the importance of the absolute configuration 
determination in rational drug design.
Although some compounds showed activity above 
the selection criteria, further biological studies 
are suggested to complete their activity profile. 
Additionally, we found some compounds with no 
antiproliferative activity like 8, 17, 19, since they 
exhibited no significant effect on the cell growth, 
indicating either no promising anticancer activity or 
the lack of previous bioactivation.
In summary, the antiproliferative effect of twenty 
compounds, related to the bicycle[3.2.1]octane 
and benzofuran neolignans, kaurane diterpene and 
diarylbutane lignans classes, obtained by isolation 
from three lauraceae plants and synthesis, was 
evaluated in vitro against six human cancer cell 
lines. Several of them showed their anticancer 
potential because they have a CL50 under 10 
mM, the reference value recommended by NCI 
Figure 4. Antiproliferative activity of compounds 7 and 20 on the 
HeLa cell line.
Figure 3. Comparison of survival rate against the logarithm of the 
tested concentration on the HeLa cell line between compound 
14 (black-line) and doxorubicin HCl (gray-line).
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for compounds (37). Three benzofuran-type 
compounds exhibited selective activity against 
HeLa cell lines, which might be used in further 
optimization studies to improve their action on the 
treatment of cervical carcinoma diseases. Kaurenoic 
acid and (-)-cinerin A were found to be the most 
potent antiproliferative compounds at reasonable 
levels, which would be good candidates to be 
used as lead compounds for further SAR studies 
for anticancer agent development. However, it is 
necessary to perform many other studies both in 
vitro and in vivo to determine their true potential for 
the development of medicines
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